Drugs · acquisition-cost intelligence
LIDOCAINE HCl
· ingredient lidocaineAnalgesics and anesthetics· LIDOCAINE HYDROCHLORIDE 40 mg/mL; LIDOCAINE HYDROCHLORIDE ANHYDROUS 40 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.24343
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 7 weeks.
2025-12-172026-05-27
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$0.21550 |
| ALCEMISTE | $0.05101 | −$0.19240 |
| Lidocaine Viscous | $0.07984 | −$0.16360 |
| Lidocaine | $0.09024 | −$0.15320 |
| lidocaine | $0.15755 | −$0.08590 |
| Cadira Compliant Blood Stat | $0.21848 | −$0.02490 |
| Lidocaine | $0.35160 | +$0.10820 |
| Acolye Numbing Cream Anorectal(Hemorrhoidal) Cream | $0.35967 | +$0.11620 |
Medicare Part D coverage · CY2026
On 227 plan formularies · typical tier 2
Prior auth 48% · Step therapy 0% · Quantity limit 64% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.